These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 19318908)

  • 1. Limited efficiency of endogenous interleukin-7 levels in T cell reconstitution during HIV-1 infection: will exogenous interleukin-7 therapy work?
    Rethi B; Vivar N; Sammicheli S; Chiodi F
    AIDS; 2009 Apr; 23(7):745-55. PubMed ID: 19318908
    [No Abstract]   [Full Text] [Related]  

  • 2. HIV-1 at the immunological and T-lymphocytic virological synapse.
    Haller C; Fackler OT
    Biol Chem; 2008 Oct; 389(10):1253-60. PubMed ID: 18713012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Editorial: Hijacking the IL-7/IL-7R system in HIV infection.
    Paiardini M
    J Leukoc Biol; 2011 Apr; 89(4):491-3. PubMed ID: 21454359
    [No Abstract]   [Full Text] [Related]  

  • 4. Progressive CD127 down-regulation correlates with increased apoptosis of CD8 T cells during chronic HIV-1 infection.
    Zhang SY; Zhang Z; Fu JL; Kang FB; Xu XS; Nie WM; Zhou CB; Zhao M; Wang FS
    Eur J Immunol; 2009 May; 39(5):1425-34. PubMed ID: 19350559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What limits immune reconstitution in HIV infection? Divergent tools converge on thymic function.
    Fry TJ; Mackall CL
    AIDS; 2001 Sep; 15(14):1881-2. PubMed ID: 11579252
    [No Abstract]   [Full Text] [Related]  

  • 6. Acetylcholine-esterase inhibitor pyridostigmine decreases T cell overactivation in patients infected by HIV.
    Valdés-Ferrer SI; Crispín JC; Belaunzarán PF; Cantú-Brito CG; Sierra-Madero J; Alcocer-Varela J
    AIDS Res Hum Retroviruses; 2009 Aug; 25(8):749-55. PubMed ID: 19645607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of early secreted antigenic target 6-specific T cell depletion after HIV-1 infection.
    Wallis RS
    J Infect Dis; 2009 Jul; 200(1):158; author reply 158-9. PubMed ID: 19485778
    [No Abstract]   [Full Text] [Related]  

  • 8. Identification and biochemical characterization of human plasma soluble IL-7R: lower concentrations in HIV-1-infected patients.
    Rose T; Lambotte O; Pallier C; Delfraissy JF; Colle JH
    J Immunol; 2009 Jun; 182(12):7389-97. PubMed ID: 19494261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics of expansion of epitope-specific T cell responses during primary HIV-1 infection.
    Turnbull EL; Wong M; Wang S; Wei X; Jones NA; Conrod KE; Aldam D; Turner J; Pellegrino P; Keele BF; Williams I; Shaw GM; Borrow P
    J Immunol; 2009 Jun; 182(11):7131-45. PubMed ID: 19454710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV's vagina travelogue.
    Boggiano C; Littman DR
    Immunity; 2007 Feb; 26(2):145-7. PubMed ID: 17307703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Approaches to immune reconstitution in HIV infection.
    Napolitano LA
    Top HIV Med; 2003; 11(5):160-3. PubMed ID: 14555803
    [No Abstract]   [Full Text] [Related]  

  • 12. [CD4 lymphocytes as targets and actors in the pathogenesis of HIV infection--therapeutic implications].
    Theze J
    Bull Acad Natl Med; 2008 Oct; 192(7):1453-66; discussion 1466-8. PubMed ID: 19445368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [T cell immune response during HIV infection and immune escape].
    Wan YM; Chou C; Zhang XY; Xu JQ
    Bing Du Xue Bao; 2008 Jul; 24(4):326-33. PubMed ID: 18780640
    [No Abstract]   [Full Text] [Related]  

  • 14. Modulating T-cell homeostasis with IL-7: preclinical and clinical studies.
    Capitini CM; Chisti AA; Mackall CL
    J Intern Med; 2009 Aug; 266(2):141-53. PubMed ID: 19623690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of T-cell exhaustion as a strategy to improve immune control of HIV-1.
    Bui JK; Mellors JW
    AIDS; 2015 Sep; 29(15):1911-5. PubMed ID: 26355569
    [No Abstract]   [Full Text] [Related]  

  • 16. Immune activation and antibody responses in non-progressing elite controller individuals infected with HIV-1.
    Bello G; Velasco-de-Castro CA; Bongertz V; Rodrigues CA; Giacoia-Gripp CB; Pilotto JH; Grinsztejn B; Veloso VG; Morgado MG
    J Med Virol; 2009 Oct; 81(10):1681-90. PubMed ID: 19697415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity in HIV suppression by CD8 T cells from HIV controllers: association with Gag-specific CD8 T cell responses.
    Sáez-Cirión A; Sinet M; Shin SY; Urrutia A; Versmisse P; Lacabaratz C; Boufassa F; Avettand-Fènoël V; Rouzioux C; Delfraissy JF; Barré-Sinoussi F; Lambotte O; Venet A; Pancino G;
    J Immunol; 2009 Jun; 182(12):7828-37. PubMed ID: 19494307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on toll-like receptor stimuli responsiveness in HIV-1 and HIV-2 infections.
    Nowroozalizadeh S; Månsson F; da Silva Z; Repits J; Dabo B; Pereira C; Biague A; Albert J; Nielsen J; Aaby P; Fenyö EM; Norrgren H; Holmgren B; Jansson M
    Cytokine; 2009 Jun; 46(3):325-31. PubMed ID: 19375940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV escape from natural killer cytotoxicity: nef inhibits NKp44L expression on CD4+ T cells.
    Fausther-Bovendo H; Sol-Foulon N; Candotti D; Agut H; Schwartz O; Debré P; Vieillard V
    AIDS; 2009 Jun; 23(9):1077-87. PubMed ID: 19424050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of HIV-1 subtype B and AE-specific neutralizing antibodies in mice and macaques with DNA prime and recombinant gp140 protein boost regimens.
    Center RJ; Wheatley AK; Campbell SM; Gaeguta AJ; Peut V; Alcantara S; Siebentritt C; Kent SJ; Purcell DF
    Vaccine; 2009 Nov; 27(47):6605-12. PubMed ID: 19712773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.